Development of Highly Optimized Antibody-Drug Conjugates against CD33 and CD123 for Acute Myeloid Leukemia

Added 246 days ago (19.01.2021)
Authors: Han, Y.-C., Kahler, J., Piche-Nicholas, N., Hu, W., Thibault, S., Jiang, F., Leal, M., Katragadda, M., Maderna, A., Dushin, R., Prashad, N., Charati, M. B., Clark, T., Tumey, L. N., Tan, X., Giannakou, A., Rosfjord, E., Gerber, H.-P., Tchistiakova, L., Loganzo, F., O'Donnell, C. J., Sapra, P.
Read article